Tracheal stent
The wavy tracheal stent design addresses displacement issues and enhances structural strength while providing controlled drug delivery, reducing complications and improving therapeutic outcomes.
Patent Information
- Application Number
- CN202420357360.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Utility models(China)
- Current Assignee / Owner
- Filing Date
- 2024-02-26
- Publication Date
- 2024-12-06
- Estimated Expiration
- 2034-02-26
AI Technical Summary
Existing tracheal stents are prone to displacement due to their cylindrical structure, leading to complications such as coughing, bleeding, and infection, and lack effective drug delivery mechanisms.
A tracheal stent with a wavy structure featuring outer protrusions and inner concave portions, covered ends for protection, and integrated drug release components with inner and outer coatings for controlled drug delivery, woven from shape memory alloy wires.
The wavy stent design enhances fixation within the trachea, reduces displacement, increases structural strength, and allows for controlled drug release, minimizing complications and improving therapeutic efficacy.
Smart Images

Figure CN222110249U_ABST
Abstract
Description
Technical Field
[0001] The utility model relates to a tracheal support. Background Art
[0002] At present, tracheal collapse refers to the phenomenon of tracheal stenosis caused by abnormal structure of the trachea itself or compression by external factors (such as tumors). Patients with tracheal collapse need to undergo tracheal collapse surgery, which improves the patient's dyspnea and hypoxia by placing a tracheal stent in the collapsed trachea. The surgical treatment effect is good. However, most tracheal stents on the market are cylindrical structures, which are prone to displacement. For example, a medical anti-proliferation stent is disclosed in a Chinese patent with publication number CN209474882U. The medical anti-proliferation stent is a cylindrical structure, which is prone to displacement when placed in the trachea. Utility Model Content
[0003] The technical problem to be solved by the utility model is to overcome the defects of the prior art and provide a tracheal stent which adopts a wavy structure and is not easy to shift. It can effectively reduce the shift phenomenon when applied in tracheal collapse surgery.
[0004] In order to solve the above technical problems, the technical solution of the utility model is: a tracheal stent, which includes a stent body;
[0005] An air flow channel is provided on the inner side of the bracket body;
[0006] The support body is provided with a plurality of outer protrusions protruding radially outward and a plurality of inner concave portions recessed radially inward, and the outer protrusions and the inner concave portions are alternately connected in sequence along the extension direction of the airflow channel to present a wave shape.
[0007] In order to further reduce the stimulation to the tracheal cavity wall, the two ends of the stent body are respectively covered with protective coatings.
[0008] In order to further release the drug, at least one drug releasing component is connected to the interior of the stent body.
[0009] A specific structure of the drug release component is further provided, wherein the drug release component comprises an inner coating and an outer coating;
[0010] The inner coating is connected to the inner wall of the inner concave portion, and a through channel is provided on the inner side of the inner coating;
[0011] The outer coating is arranged around the outer side of the inner coating and connected to the outer wall of the inner coating, and a drug-carrying cavity for storing drugs is formed between the outer coating and the inner coating;
[0012] The inner layer coating is provided with an inner sustained-release hole connected to the drug loading cavity and used for releasing the drug in the drug loading cavity, and the outer layer coating is provided with an outer sustained-release hole connected to the drug loading cavity and used for releasing the drug in the drug loading cavity.
[0013] Furthermore, a cavity is provided on the inner side of the outer convex portion, and the outer coating is located in the corresponding cavity;
[0014] The upper end of the inner coating is connected to the inner wall of one of the inner recessed parts, and the lower end of the inner coating is connected to the inner wall of the other inner recessed part.
[0015] Furthermore, the inner coating is a cylindrical structure.
[0016] Furthermore, the drug loading cavity is an annular structure.
[0017] Furthermore, a plurality of the outer sustained-release holes are sequentially spaced and distributed along the circumference of the outer coating.
[0018] Furthermore, a plurality of inner sustained-release holes are sequentially spaced and distributed along the circumference of the inner coating.
[0019] Furthermore, the stent body is woven from shape memory alloy wires.
[0020] After adopting the above technical solution, the stent body is provided with a plurality of outer protrusions protruding radially outward and a plurality of inner concave portions recessed radially inward, and the outer protrusions and the inner concave portions are alternately connected in sequence along the extension direction of the airflow channel to present a wave shape. The stent body adopts a wavy structure, which can better fit and fix with the wall of the tracheal cavity, so it is not easy to shift. When the wavy stent body is used in tracheal collapse surgery, the phenomenon of displacement can be effectively reduced. In addition, the stent body with a wavy structure has a higher structural strength, can withstand greater pressure, has the characteristics of stress dispersion, and can effectively avoid the problem of stent body breakage. BRIEF DESCRIPTION OF THE DRAWINGS
[0021] Figure 1 This is a schematic diagram of the external structure of the tracheal stent of the utility model;
[0022] Figure 2 It is a schematic diagram of the internal structure of the tracheal stent of the utility model. DETAILED DESCRIPTION
[0023] In order to make the content of the utility model more clearly understood, the utility model is further described in detail below based on specific embodiments and in conjunction with the accompanying drawings.
[0024] like Figure 1 , 2As shown, a tracheal stent comprises a stent body 1;
[0025] An air flow channel 2 is provided on the inner side of the bracket body 1;
[0026] The stent body 1 is provided with a plurality of outer protrusions 3 protruding radially outward and a plurality of inner recesses 4 recessed radially inward, and the outer protrusions 3 and the inner recesses 4 are alternately connected in sequence along the extension direction of the airflow channel 2 to present a wave shape. Specifically, the stent body 1 adopts a wavy structure, which can better fit and fix with the wall of the tracheal cavity, so it is not easy to shift. When the wavy stent body 1 is used in tracheal collapse surgery, the phenomenon of displacement can be effectively reduced. In addition, the stent body 1 with a wavy structure has a higher structural strength, can withstand greater pressure, has the characteristics of stress dispersion, and can effectively avoid the problem of the stent body 1 breaking.
[0027] like Figure 1 As shown, the two ends of the stent body 1 are respectively covered with a protective coating 5; specifically, the two ends of the stent body 1 will cause stimulation when in contact with the wall of the tracheal cavity, which may easily cause symptoms such as coughing in patients; in this embodiment, a protective coating 5 is provided at the two ends of the stent body 1, and the protective coating 5 can prevent the two ends of the stent body 1 from contacting with the wall of the tracheal cavity, thereby reducing the stimulation to the wall of the tracheal cavity and avoiding postoperative complications such as coughing, bleeding, and infection.
[0028] like Figure 2 As shown, at least one drug releasing component 6 is connected to the inside of the stent body 1; specifically, the drug releasing component 6 is used to place various drugs to achieve a therapeutic effect, and two or more drug releasing components 6 can be provided as needed; in this embodiment, two drug releasing components 6 are provided.
[0029] like Figure 2 As shown, the drug release component 6 may include an inner coating 7 and an outer coating 8;
[0030] The inner coating 7 is connected to the inner wall of the inner recess 4, and a through channel 9 is provided on the inner side of the inner coating 7;
[0031] The outer coating 8 is disposed around the outer side of the inner coating 7 and connected to the outer wall of the inner coating 7. A drug-carrying cavity 10 for storing drugs is formed between the outer coating 8 and the inner coating 7.
[0032] The inner coating 7 is provided with inner sustained-release holes 11 which are connected to the drug-carrying cavity 10 and used to release the drug in the drug-carrying cavity 10, and the outer coating 8 is provided with outer sustained-release holes 12 which are connected to the drug-carrying cavity 10 and used to release the drug in the drug-carrying cavity 10; specifically, the stent body 1 is a hollow mesh structure, and the drug in the drug-carrying cavity 10 can be slowly released outward from the inner sustained-release holes 11 and the outer sustained-release holes 12, and then enter the trachea and exert its efficacy.
[0033] like Figure 2 As shown, a cavity 13 is provided on the inner side of the outer convex portion 3, and the outer coating 8 is located in the corresponding cavity 13;
[0034] The upper end of the inner coating 7 is connected to the inner wall of one of the inner recesses 4 , and the lower end of the inner coating 7 is connected to the inner wall of the other inner recess 4 .
[0035] like Figure 2 As shown, the inner coating 7 is a cylindrical structure, the drug loading cavity 10 is an annular structure, a plurality of outer sustained-release holes 12 are sequentially spaced along the circumference of the outer coating 8, and a plurality of inner sustained-release holes 11 are sequentially spaced along the circumference of the inner coating 7; in the present embodiment, the inner sustained-release holes 11 and the outer sustained-release holes 12 are evenly distributed in number of 12, respectively.
[0036] Specifically, the stent body 1 is woven from shape memory alloy wires.
[0037] In summary, the stent body 1 is provided with a plurality of outer protrusions 3 protruding radially outward and a plurality of inner recesses 4 recessed radially inward, and the outer protrusions 3 and the inner recesses 4 are alternately connected in sequence along the extension direction of the airflow channel 2 to present a wave shape. The stent body 1 adopts a wavy structure, which can better fit and fix with the wall of the tracheal cavity, so it is not easy to shift. When the wavy stent body 1 is used in tracheal collapse surgery, the displacement phenomenon can be effectively reduced. In addition, the stent body 1 with a wavy structure has a higher structural strength, can withstand greater pressure, has the characteristics of stress dispersion, and can effectively avoid the problem of the stent body 1 breaking.
[0038] The specific embodiments described above further illustrate the technical problems, technical solutions and beneficial effects solved by the present invention. It should be understood that the above are only specific embodiments of the present invention and are not intended to limit the present invention. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principles of the present invention should be included in the protection scope of the present invention.
Claims
1. A tracheal stent, characterized in that: It comprises a support body (1); An air flow channel (2) is provided on the inner side of the support body (1); The support body (1) is provided with a plurality of outer protrusions (3) protruding radially outward and a plurality of inner concave sections (4) recessed radially inward, and the outer protrusions (3) and the inner concave sections (4) are connected alternately in sequence along the extension direction of the airflow channel (2) to present a wave shape.
2. The tracheal stent according to claim 1, characterized in that: Both ends of the bracket body (1) are respectively covered with protective coatings (5).
3. The tracheal stent according to claim 1, characterized in that: At least one drug releasing component (6) is connected to the interior of the stent body (1).
4. The tracheal stent according to claim 3, characterized in that: The drug release component (6) comprises an inner coating (7) and an outer coating (8); The inner coating (7) is connected to the inner wall of the inner recess (4), and a through channel (9) is provided on the inner side of the inner coating (7); The outer coating (8) is arranged around the outer side of the inner coating (7) and connected to the outer wall of the inner coating (7), and a drug-carrying cavity (10) for storing drugs is formed between the outer coating (8) and the inner coating (7); The inner layer coating (7) is provided with an inner sustained-release hole (11) which is connected to the drug-carrying cavity (10) and is used to release the drug in the drug-carrying cavity (10), and the outer layer coating (8) is provided with an outer sustained-release hole (12) which is connected to the drug-carrying cavity (10) and is used to release the drug in the drug-carrying cavity (10).
5. The tracheal stent according to claim 4, characterized in that: A concave cavity (13) is provided on the inner side of the outer convex portion (3), and the outer coating (8) is located in the corresponding concave cavity (13); The upper end of the inner layer coating (7) is connected to the inner wall of one of the inner recesses (4), and the lower end of the inner layer coating (7) is connected to the inner wall of the other inner recess (4).
6. The tracheal stent according to claim 4, characterized in that: The inner coating (7) is a cylindrical structure.
7. The tracheal stent according to claim 4, characterized in that: The drug-carrying cavity (10) is an annular structure.
8. The tracheal stent according to claim 4, characterized in that: A plurality of the outer sustained-release holes (12) are sequentially spaced and distributed along the circumference of the outer coating (8).
9. The tracheal stent according to claim 4, characterized in that: A plurality of the inner sustained-release holes (11) are sequentially spaced and distributed along the circumference of the inner coating (7).
10. The tracheal stent according to claim 1, characterized in that: The stent body (1) is woven from shape memory alloy wires.
